Overview

BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is designed to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500 in patients with diabetes and severe insulin resistance.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Biodel
Treatments:
Biphasic Insulins
Insulin
Insulin Lispro
Insulin, Globin Zinc
Insulin, Isophane